Allelix Biopharmaceuticals Inc. and Verax Corp. have formed analliance to provide bioprocessing expertise to thepharmaceutical industry worldwide, the companies said.

Under the agreement, Allelix (TSE:AXB) will make available toVerax customers its expertise in bacterial and fungalexpression systems. Verax of Lebanon, N.H., is a provider ofbioreactors, products and contract manufacturing services withexpertise in mammalian cell culture.

The deal will give Allelix access to Verax's customer base andwill generate contract revenues for Allelix, said Jerry Ormiston,business development coordinator at the Toronto company.Privately held Verax, in turn, will be able to provide a widerrange of services to its customers, Ormiston said.

Other terms weren't disclosed.

(c) 1997 American Health Consultants. All rights reserved.